Skip to main content

Table 1 Episodes of febrile neutropenia by diagnosis in 275 pediatric oncology patients.

From: Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia

Diagnosis

Number of patients (%)

Number of patients with FN episodes (%)

Mean number of episodes per patient

Range of number of episodes per patient

Osteogenic sarcoma

8 (3%)

7 (87%)

3.13

0–7

Ewings sarcoma

5 (2%)

4 (80%)

2.20

0–5

Rhabdomyosarcoma

15 (5%)

11 (79%)

1.93

0–6

Hepatoblastoma

9 (3%)

5 (56%)

1.22

0–5

Acute myeloid leukemia (AML)

16 (6%)

7 (44%)

1.00

0–5

Neuroblastoma

23 (8%)

11 (48%)

0.83

0–5

Non-Hodgkin's lymphoma

24 (9%)

14 (58%)

0.75

0–4

Acute lymphoblastic leukemia (ALL)

85 (31%)

41 (48%)

0.73

0–7

Others *

22 (8%)

9 (41%)

0.41

0–3

Hodgkin's lymphoma

25 (9%)

8 (32%)

0.36

0–5

Central nervous system tumors

26 (9%)

7 (27%)

0.23

0–3

Wilms tumor

17 (6%)

3 (18%)

0.12

0–1

Total

275

127 (46%)

  
  1. Children with leukemia not in remission were excluded. All but a small number of children with neuroblastoma and central nervous system tumors received chemotherapy.
  2. n = number of patients
  3. * adrenocortical carcinoma, epithelial tumor, juvenile myelomonocytic leukemia, Langerhans cell histiocytosis, small cell tumor, teratoma